awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
Graphs
1
Q38925574-934098B3-4AF5-444C-AF06-1DE82F06B749
Q38925574-934098B3-4AF5-444C-AF06-1DE82F06B749
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38925574-934098B3-4AF5-444C-AF06-1DE82F06B749
Psoriasis patients with psoriasis Area and Severity Index (PASI) 90 response achieve greater health-related quality-of-life improvements than those with PASI 75-89 response: results from two phase 3 studies of secukinumab.
P2860
Q38925574-934098B3-4AF5-444C-AF06-1DE82F06B749
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38925574-934098B3-4AF5-444C-AF06-1DE82F06B749
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
1dcbfe8e48915002f34eb68429b27a226d614352
P2860
New and emerging biologic therapies for moderate-to-severe plaque psoriasis: mechanistic rationales and recent clinical data for IL-17 and IL-23 inhibitors